{"id":"W2036437506","doi":"10.1016/j.lungcan.2004.06.004","title":"Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial","year":2004,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Vindesine; Medicine; Cisplatin; Oncology; Mitomycin C; Chemotherapy; Internal medicine; Induction chemotherapy; Lung cancer; Stage (stratigraphy); Surgery; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001100242,0.00125293,0.001644224,0.0002762793,0.0004438186,0.000679804,0.001039932,0.0008244853,0.002790091],"category_scores_gemma":[0.0007466293,0.0002682477,0.001091102,0.0005683602,0.0007540319,0.0004857808,0.0003846205,0.001704241,0.0005170672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003875104,"about_ca_system_score_gemma":0.003527846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03655342,"about_ca_topic_score_gemma":0.131028,"domain_scores_codex":[0.9997051,0.0001221769,0.00001141386,0.00004183992,0.00003906823,0.00008026238],"domain_scores_gemma":[0.9992945,0.00009837623,0.0001279083,0.00004924065,0.00003804457,0.0003918531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7573318,0.01177569,0.01281845,0.001514837,0.002795383,0.0002071082,0.0005128433,0.006346896,0.01281087,0.0007918347,0.01651926,0.1765751],"study_design_scores_gemma":[0.7139795,0.1917429,0.07581075,0.0001835056,0.001930325,0.0002737417,0.0001698333,0.002253034,0.002714869,0.000427498,0.01046084,0.00005307768],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835144,0.006390499,0.0003709946,0.000867688,0.0001532669,0.001250427,0.002343072,0.0001060754,0.005003544],"genre_scores_gemma":[0.9807845,0.005755276,0.001359993,0.0008829635,0.0001350667,0.001069628,0.005249097,0.00003174759,0.004731681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03655342,"threshold_uncertainty_score":0.07268131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01791368138287724,"score_gpt":0.3282780373517002,"score_spread":0.3103643559688229,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}